According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention

Company Pfizer

Rational Pharmacotherapy in Cardiology
Racionalʹnaâ farmakoterapiâ v kardiologii

eng | рус

User

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)

Rational Pharmacotherapy in Cardiology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention. Rational Pharmacotherapy in Cardiology. 2019;15(4):604-606. (In Russ.)

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)

Username
Password
	Remember me

User

Rational Pharmacotherapy in Cardiology

For citations:

Cookies policy